Solana Company Rebrands, Aligns with Solana Foundation, and Eyes SOL Token Acquisition

Helius Medical Technologies has rebranded to Solana Company (HSDT), maintaining its ticker symbol HSDT. The company is aligning with the Solana Foundation to enhance blockchain capabilities and has options to acquire SOL tokens. A recent $500 million PIPE financing supports HSDT's digital asset strategy, focusing on SOL token accumulation.

Helius Medical Technologies, Inc. (Nasdaq: HSDT), a leading neurotech company, has rebranded as Solana Company, reflecting a strategic shift towards the blockchain sector. The company has entered into a non-binding agreement with the Solana Foundation, which includes terms such as conducting all on-chain activities exclusively on the Solana blockchain, hosting events to highlight the network's capabilities, and partnering on institutional referrals Nasdaq-listed Helius Medical Technologies rebrands as Solana Company^[1].

The rebrand comes after Helius Medical Technologies raised $500 million through a PIPE (Private Investment in Public Equity) financing round, with proceeds earmarked for establishing a digital asset treasury strategy centered on SOL tokens Preeminent SOL Treasury Company Helius (NASDAQ: ...^[2]. This move aligns with the company's long-term vision to maximize SOL per share on one of the most commercially viable blockchains for consumer applications while delivering consistent on-chain yield for investors Nasdaq-listed Helius Medical Technologies rebrands as Solana Company^[1].

Solana Company will benefit from discounted SOL tokens and joint initiatives with the Solana Foundation. The company's digital asset treasury strategy aims to leverage SOL's yield-bearing mechanism, which offers approximately 7% native staking yield, to magnify returns on its crypto holdings Nasdaq-listed Helius Medical Technologies rebrands as Solana Company^[1].

Dan Morehead, HSDT's strategic advisor and Pantera Capital's managing partner, underscored the significance of this move: "DATs are providing access to the blockchain market to a new kind of investor. Solana Company is well set up to be the preeminent SOL DAT by introducing Solana to a growing audience" Nasdaq-listed Helius Medical Technologies rebrands as Solana Company^[1].

Solana's native token, SOL, has shown resilience in the market, trading at $208 following a 2% increase in its daily chart, as of September 12, 2025. The global crypto market cap has increased by over 2.7% in the past day to $3.9 trillion, indicating improving sentiments Nasdaq-listed Helius Medical Technologies rebrands as Solana Company^[1].

The rebrand and strategic alignment with the Solana Foundation position Solana Company as a powerful advocate for Solana's development, aiming to accelerate the growth of the blockchain network Nasdaq-listed Helius Medical Technologies rebrands as Solana Company^[1].